Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Study provides complete picture of HPV virus-head and neck cancer connections

Human papillomavirus is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils.

12 Sep 2018

Five microRNAs predict course, recurrence of HPV-negative head and neck cancer

A new method predicts the course of HPV-negative head and neck cancer after radiation chemotherapy.

4 Sep 2018

Screening for HPV could replace routine Pap smears

According to health advisors from the U.S. Preventive Services Task Force, Pap smears may not be the only way to check for cervical cancer risk among women.

22 Aug 2018

Comprehensive analysis informs new recommendation for national cervical cancer screening

A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.

21 Aug 2018

Genital warts may promote HIV sexual transmission

A new study has shown that genital warts may promote HIV sexual transmission and, in turn, their treatment and prevention could help decrease the spread of the disease.

21 Aug 2018

Discovery may help broaden the scope of defenses against HPV

Yale Cancer Center scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus infects cells.

16 Aug 2018

Vaccine schedule is a must-have on child’s back-to-school checklist

With the start of the school year just around the corner, it is easy to overlook one of the most important things on any back-to-school checklist -; making sure your child is vaccinated. Vaccinations protect children from serious diseases, ultimately protecting families, schools and communities by way of safe and effective immunizations.

1 Aug 2018

HPV vaccines for boys in UK

The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.

25 Jul 2018

HPV test better than Pap when screening for cervical cancer

The Pap smear test has been used widely for the past five decades to understand and screen for early signs of cervical cancer. The conventional test has been largely replaced by a liquid-based Pap cytology test. Soon it may be replaced by another test – the Human papilloma virus test or the HPV test finds new research.

4 Jul 2018

Parents believe cancer prevention potential as best reason for adolescents to receive HPV vaccine

Parents of adolescents believed that the potential to prevent certain types of cancer is the best reason for their children to receive the human papillomavirus vaccine, whereas other reasons health care providers often give were far less persuasive.

14 Jun 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

Scientists examine viability of using new microwave system to treat HPV

University of Glasgow are leading new tests into the viability of using an innovative, new microwave system to treat human papillomavirus (HPV).

7 Mar 2018

Research shows how viruses inactivate immune system, causing cancer

It's no new news that viruses cause cancer. For example, human papillomavirus causes almost all of the more than 500,000 annual worldwide cases of cervical cancer.

2 Mar 2018

UH researcher examines role of estrogen in cervical cancer

Two University of Houston researchers, working to find cancer cures, received grants from the Cancer Prevention & Research Institute of Texas, the organization that funds groundbreaking cancer research and prevention programs in the state.

1 Mar 2018

Self-sampling followed by HPV testing can benefit women at risk of cervical cancer

Using self-sampling followed by HPV testing, more than twice as many women at risk of developing cervical cancer could be identified and offered preventive treatment.

16 Feb 2018

Gene editing tool used to detect cancer

Researchers have developed a DNA detection system that can detect the presence of bacterial and viral DNA, which could be a valuable diagnostic tool for a range of disorders.

16 Feb 2018

Cervical tumors may be vulnerable to therapies that attack cancer's fuel supply, study shows

Cancer therapies have improved -- in some cases dramatically -- over the past two decades, but treatment for cervical cancer has remained largely unchanged. All patients receive radiation and chemotherapy, yet despite the aggressive approach, the regimen fails in about one-third of patients with cervical cancer that has spread beyond the cervix but not outside the pelvis.

15 Feb 2018

CAP releases new guideline for HPV testing in patients with head and neck cancers

Certain head and neck cancers that are positive for high-risk types of human papillomavirus (HPV) have a better prognosis and may need less aggressive treatment.

11 Jan 2018

Risk of cervical cancer may dramatically increase in older women, study states

According to a new study published in The Lancet Public Health, the incidence of cervical cancer in older women may drastically increase; however, it is expected to reduce by 75% in young women by 2040.

19 Dec 2017

Older women to face greater risk of cervical cancer diagnoses and deaths

Incidence of cervical cancer in young women is set to decline 75 percent by 2040 with deaths close to eradicated, however older women will face greater risk according to research led by Queen Mary University of London, published today in The Lancet Public Health.

18 Dec 2017